Florence, the company advancing clinical research through software, and Verady, a Blockchain asset assurance company, has announced a partnership to develop healthcare blockchain apps for advancing healthcare and clinical research. As part of the partnership, Verady’s Application Programming Interface (API) will provide an easy-to-use, standardized Representational State Transfer (ReST) interface to abstract away the complexities of Blockchain for Florence’s customers. The partnership will be developing open source Blockchain apps for managing patient and clinical trial data, in conjunction with several pharmaceutical sponsors.
lorence is the fastest growing workflow tool in clinical research and manages patient and trial data for thousands of clinical investigators and research sponsors. Verady develops technologies that make asset assurance through Blockchain easy and secure. As part of the partnership, Verady’s Application Programming Interface (API) will provide an easy-to-use, standardized Representational State Transfer (ReST) interface to abstract away the complexities of Blockchain for Florence’s customers.
“The Florence-Verady partnership allows research sites and pharmaceutical companies more control over patient data through Blockchain,” says Florence CTO, Andres Garcia in a statement. “Patient and clinical trial data managed through the Verady API allows research teams to take advantage of terabytes of patient data while respecting patient rights.”
